TNFRSF6B and bladder transitional cell carcinoma: DcR3 expression level also correlates positively with clinicopathological change in bladder urothelial carcinoma [34], breast cancer [32], pancreatic head carcinoma [35], colorectal cancer (CRC) [36], gastrointestinal cancer [37, 38], and female reproductive carcinoma [39].